Bilal Arshad Khan - 09 Feb 2026 Form 4 Insider Report for SpyGlass Pharma, Inc. (SGP)

Role
Director
Signature
/s/ Brian Aukshunas, as Attorney-in-Fact
Issuer symbol
SGP
Transactions as of
09 Feb 2026
Net transactions value
+$2,160,000
Form type
4
Filing time
11 Feb 2026, 16:07:19 UTC
Previous filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Khan Bilal Arshad Director C/O SPYGLASS PHARMA, INC., 27061 ALISO CREEK RD., SUITE 100, ALISO VIEJO /s/ Brian Aukshunas, as Attorney-in-Fact 11 Feb 2026 0002108044

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGP Common Stock Purchase $320,000 +20,000 +367% $16.00 25,450 09 Feb 2026 Direct
transaction SGP Common Stock Purchase $1,840,000 +115,000 +84% $16.00 251,427 09 Feb 2026 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by New World Medical, Inc. (New World Medical). The Reporting Person is the Chief Executive Officer of New World Medical and as such has voting and investment control over the shares held by New World Medical. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of their pecuniary interest in the shares.